Ophthotech Corporation Securities Fraud Class Action

VIEW COMPLAINT

Please complete this form and list your purchase and sale transaction(s) for Ophthotech Corporation (NasdaqGS: OPHT) securities between March 2, 2015, and December 12, 2016, both dates inclusive (the “Class Period”):

You may also contact James Maro, Jr., Esq. toll free at 844.887.9500, or you may submit your information via email at info@ktmc.com, or you may click here to print a PDF of this form.

Information Sheet

* Denotes required field

First Name *

Last Name *

Email *

Country

City

State\Province

Zip\Postal Code

Country Prefix

Phone Number

Phone Type

Purchase(s)

+ Additional Purchases

Sale(s)

+ Additional Sales

Date

# of Shares

Price per Share

Date

Principal Amount

Amount Paid

Series or CUSIP

Date

# of Contracts

Price per Contract

Exercise Price

Expiration Date

Did you purchase shares of Ophthotech Corporation prior to the Class Period?

Yes

Are you a current or former employee of Ophthotech Corporation ?

Yes

The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.

I agree to the KTMC
disclaimer

Yes

I would like to receive
new case alerts by email

Yes

Submit Your Information

COMPANY	Ophthotech Corporation
COURT	United States District Court for the Southern District of New York
CASE NUMBER	17-cv-00210
JUDGE	The Hon. Vernon S. Broderick
CLASS PERIOD	March 2, 2015 - December 12, 2016
SECURITY TYPE	Common Stock

Case Background:

On January 11, 2017, the initial complaint in this securities class action was filed against Ophthotech Corporation (“Ophthotech”), and certain of Ophthotech’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.

Lead Plaintiff alleges that defendants disseminated materially false and misleading statements and/or concealed material adverse facts. Specifically, defendants engaged in a scheme which: (i) deceived the investing public regarding Ophthotech’s business and prospects and the intrinsic value of Ophthotech common stock; (ii) enabled the Individual Defendants to collectively sell over $45 million worth of Ophthotech common stock to the unsuspecting public at artificially inflated prices at times and in amounts that were unusual; and (iii) caused Lead Plaintiff and other members of the Class to purchase Ophthotech common stock at artificially inflated prices.

Current Status of Case:

On June 12, 2020, Lead Plaintiff filed its motion for class certification. This unopposed motion is pending before the Court. All fact discovery is to be completed no later than June 18, 2021. This action is still ongoing.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.